(WPI) Watson Pharmaceuticals – Bull of the Day

Based on its first quarter performance and increased guidance, we are upgrading Watson Pharmaceuticals (WPI) to Outperform. The company posted first-quarter 2011 earnings of $0.89 per share, beating the Zacks Consensus Estimate by $0.03 and the year-ago earnings by $0.08 per share. Revenues increased 2% to $876.5 million, mainly driven by higher generics sales.

Watson Pharma increased its 2011 earning guidance range to $3.95 – $4.20 per share from $3.85 – $4.15 per share. Following the earnings announcement, we raised our 2011 earnings estimate by 14 cents to $4.29 per share.

We believe that the company’s cost saving initiatives and new product launches, both branded and generic, will help drive growth. Our target price of $82 is based on 19.1x our 2011 EPS estimate.

WATSON PHARMA (WPI): Free Stock Analysis Report

Zacks Investment Research

About vitalstocks

This is a sample profile field. Vitalstocks is the operating company for Stockbloghub. This will place the picture of the author or company in the profile. Here is another extra line of information.


Powered by Facebook Comments

Similar Posts: | | Drugs - Generic | Healthcare

RSS feeds: Watson Pharmaceuticals Inc. | WPI | Drugs - Generic | Healthcare |

Other Posts by | RSS Feed for this author